Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02953704 · ClinicalTrials.gov registry record
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
A clinical trial, sponsored by Incyte Corporation.
- Completed
- Registry status
- 1,469
- Enrollment target
NCT02953704 is a clinical trial that has completed, run by Incyte Corporation. The registered enrollment target is 1,469 participants.
The verdict
NCT02953704 has completed, sponsored by Incyte Corporation.
- COMPLETED
- Registry status
- 1,469 participants
- Enrollment target
Study Summary
The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,469 participants |
| Start Date | 2016-12-31 |
| Est. Completion | 2022-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02953704
The ClinicalTrials.gov registry entry for NCT02953704 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,469 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02953704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02953704 about?
NCT02953704 is a clinical study titled "Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)". The purpose of this prospective, longitudinal, noninterventional study is to describe clinical characteristics, evolution of disease burden, and treatment patterns in patients with select subcategories of essential thrombocythemia (ET) or myelofibrosis (MF).
What is the current status of trial NCT02953704?
This trial is currently completed. The enrollment target is 1,469 participants. The study started on 2016-12-31. Estimated completion is 2022-03-29.
Who is sponsoring clinical trial NCT02953704?
This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.